Coronary in-stent restenosis  

作　　者：张金国 刘洪岩 廖玉华 

机构地区：[1]Department of Cardiology,Affiliated Hospital of Jining Medical College,Key Lab of Heart Disease Diagnose and Treatment in Shandong Province [2]Department of Cardiology,The people's Hospital of Laiwu City [3]Institute of Cardiology,Union Hospital,Tongji Medical College of Huazhong University of Science and Technology

出　　处：《South China Journal of Cardiology》2012年第2期127-133,共7页岭南心血管病杂志（英文版）

摘　　要：widely used development incidence of factors and Coronary stent implantation was considered as a way of coronary revascularization. It has been in the treatment of coronary heart disease, but restenosis has become the main bottleneck to the of stent technique. Despite drug-eluting stents used widely, restenosis rate is still about 10%. The restenosis was associated with intervention injury, patient factors, genetic types, nerve endocrine so on Overview above aspects is expected to provide some ideas for restenosis prevention and treatment.widely used development incidence of factors and Coronary stent implantation was considered as a way of coronary revascularization. It has been in the treatment of coronary heart disease, but restenosis has become the main bottleneck to the of stent technique. Despite drug-eluting stents used widely, restenosis rate is still about 10%. The restenosis was associated with intervention injury, patient factors, genetic types, nerve endocrine so on Overview above aspects is expected to provide some ideas for restenosis prevention and treatment.

关 键 词：coronary revascularization coronary stent implantation drug-eluting stent RESTENOSIS RATE 

分 类 号：R541.4[医药卫生—心血管疾病]